Literature DB >> 23179416

How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis.

Vibhore Prasad1, Ellen Brogan, Caroline Mulvaney, Matthew Grainge, Wendy Stanton, Kapil Sayal.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) has a significant impact on children's classroom behaviour, daily functioning and experience of school life. However, the effects of drug treatment for ADHD on learning and academic achievement are not fully understood. This review was undertaken to describe the effects of methylphenidate, dexamfetamine, mixed amfetamine salts and atomoxetine on children's on-task behaviour and their academic performance, and to perform a meta-analysis to quantify these effects. Nine electronic databases were systematically searched for randomized controlled trials comparing drug treatment for ADHD against (i) no drug treatment, (ii) baseline (in crossover trials), or (iii) placebo; reporting outcomes encompassing measures of educational achievement within the classroom environment. Forty-three studies involving a pooled total of 2,110 participants were identified for inclusion. Drug treatment benefited children in the amount of school work that they completed, by up to 15%, and less consistently improved children's accuracy in specific types of academic assignments, such as arithmetic. Similar improvements were seen in classroom behaviour, with up to 14% more of children's time spent "on task". Methylphenidate, dexamfetamine and mixed amfetamine formulations all showed beneficial effects on children's on-task behaviour and academic work completion. Atomoxetine was examined in two studies, and was found to have no significant effect. These review findings suggest that medication for ADHD has the potential to improve children's learning and academic achievement.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23179416     DOI: 10.1007/s00787-012-0346-x

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  65 in total

1.  Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.

Authors:  Anil Chacko; William E Pelham; Elizabeth M Gnagy; Andrew Greiner; Gary Vallano; Oscar Bukstein; Michael Rancurello
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-03       Impact factor: 8.829

2.  Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning.

Authors:  Ronald T Brown; Amy Perwien; Douglas E Faries; Christopher J Kratochvil; Brigette S Vaughan
Journal:  Clin Pediatr (Phila)       Date:  2006-11       Impact factor: 1.168

3.  Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.

Authors:  Erin B Gorman; Rafael Klorman; Joan E Thatcher; Agneta D Borgstedt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-07       Impact factor: 8.829

4.  Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.

Authors:  R S James; W S Sharp; T M Bastain; P P Lee; J M Walter; M Czarnolewski; F X Castellanos
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-11       Impact factor: 8.829

5.  Adult psychiatric status of hyperactive boys grown up.

Authors:  S Mannuzza; R G Klein; A Bessler; P Malloy; M LaPadula
Journal:  Am J Psychiatry       Date:  1998-04       Impact factor: 18.112

6.  A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Authors:  W E Pelham; H R Aronoff; J K Midlam; C J Shapiro; E M Gnagy; A M Chronis; A N Onyango; G Forehand; A Nguyen; J Waxmonsky
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

7.  Classroom academic performance: improvement with both methylphenidate and dextroamphetamine in ADHD boys.

Authors:  J Elia; P A Welsh; C S Gullotta; J L Rapoport
Journal:  J Child Psychol Psychiatry       Date:  1993-07       Impact factor: 8.982

8.  Differential effects of methylphenidate and self-reinforcement on attention-deficit hyperactivity disorder.

Authors:  O Ajibola; P W Clement
Journal:  Behav Modif       Date:  1995-04

9.  The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.

Authors:  Brooke S G Molina; Stephen P Hinshaw; James M Swanson; L Eugene Arnold; Benedetto Vitiello; Peter S Jensen; Jeffery N Epstein; Betsy Hoza; Lily Hechtman; Howard B Abikoff; Glen R Elliott; Laurence L Greenhill; Jeffrey H Newcorn; Karen C Wells; Timothy Wigal; Robert D Gibbons; Kwan Hur; Patricia R Houck
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-05       Impact factor: 8.829

10.  Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

Authors:  James T McCracken; Joseph Biederman; Laurence L Greenhill; James M Swanson; James J McGough; Thomas J Spencer; Kelly Posner; Sharon Wigal; Caroly Pataki; Yuxin Zhang; Simon Tulloch
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-06       Impact factor: 8.829

View more
  30 in total

1.  Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.

Authors:  Tanya E Froehlich; Jason Fogler; William J Barbaresi; Nada A Elsayed; Steven W Evans; Eugenia Chan
Journal:  Clin Pharmacol Ther       Date:  2018-08-30       Impact factor: 6.875

2.  Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication.

Authors:  Andreas Jangmo; Amanda Stålhandske; Zheng Chang; Qi Chen; Catarina Almqvist; Inna Feldman; Cynthia M Bulik; Paul Lichtenstein; Brian D'Onofrio; Ralf Kuja-Halkola; Henrik Larsson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-02-02       Impact factor: 8.829

3.  Attention-deficit/hyperactivity disorder: seeking the right balance between over- and undertreatment.

Authors:  Pieter J Hoekstra; Andrea Dietrich
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08       Impact factor: 4.785

Review 4.  Neuropharmacology of attention.

Authors:  Joshua A Burk; Sarah A Blumenthal; Eden B Maness
Journal:  Eur J Pharmacol       Date:  2018-08-06       Impact factor: 4.432

Review 5.  Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Authors:  Jochen Antel; Özgür Albayrak; Gerd Heusch; Tobias Banaschewski; Johannes Hebebrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-23       Impact factor: 5.270

6.  Speed and complexity characterize attention problems in children with localization-related epilepsy.

Authors:  Madison M Berl; Virginia Terwilliger; Alexandra Scheller; Leigh Sepeta; Jenifer Walkowiak; William D Gaillard
Journal:  Epilepsia       Date:  2015-05-04       Impact factor: 5.864

7.  Acute effects of methylphenidate on impulsivity and attentional behavior among adolescents comorbid for ADHD and conduct disorder.

Authors:  Donald M Dougherty; Rene L Olvera; Ashley Acheson; Nathalie Hill-Kapturczak; Stacy R Ryan; Charles W Mathias
Journal:  J Adolesc       Date:  2016-11-02

8.  Attention-Deficit/Hyperactivity Disorder-Related Deficits and Psychostimulant Medication Effects on Comprehension of Audiovisually Presented Educational Material in Children.

Authors:  Sarah A Orban; Tanya A Karamchandani; Leanne Tamm; Craig A Sidol; James Peugh; Tanya E Froehlich; William B Brinkman; Nicole Estell; Akemi E Mii; Jeffery N Epstein
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-08-27       Impact factor: 2.576

Review 9.  Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?

Authors:  Raman Baweja; Richard E Mattison; James G Waxmonsky
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

10.  Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.

Authors:  James T McCracken; James J McGough; Sandra K Loo; Jennifer Levitt; Melissa Del'Homme; Jennifer Cowen; Alexandra Sturm; Fiona Whelan; Gerhard Hellemann; Catherine Sugar; Robert M Bilder
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-06-03       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.